Liver Cancer Trial, Recruiting (NCT07469319)

Liver Cancer Trial, Recruiting NCT07469319 Sponsor: University of Aarhus Condition: Liver Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT07469319 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Liver Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with cirrhosis (scarring of the liver)
You do not have a history of chronic hepatitis B or C
Your cirrhosis is considered "compensated," meaning you have not had recent bleeding from swollen veins in your digestive tract, your fluid build-up in the abdomen is controlled, you do not have obvious signs of confusion caused by liver problems, and your liver function score (Child-Pugh score) is 8 or below (confirm with trial site)
You are between 40 and 79 years old
You are expected to live for at least 1 more year
You are not currently being monitored or followed up after treatment for liver cancer (HCC)
There is no current suspicion that you have liver cancer (HCC)

Who may not be able to join:

No specific exclusion criteria have been listed for this trial (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 20 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +45 29314466

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07469319

Sponsor: University of Aarhus

Phase: Not Applicable

Status: Recruiting

Condition: Liver Cancer

Trial contact: +45 29314466

More information: https://clinicaltrials.gov/study/NCT07469319

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with cirrhosis (scarring of the liver)
You do not have a history of chronic hepatitis B or C
Your cirrhosis is considered "compensated," meaning you have not had recent bleeding from swollen veins in your digestive tract, your fluid build-up in the abdomen is controlled, you do not have obvious signs of confusion caused by liver problems, and your liver function score (Child-Pugh score) is 8 or below (confirm with trial site)
You are between 40 and 79 years old
You are expected to live for at least 1 more year
You are not currently being monitored or followed up after treatment for liver cancer (HCC)
There is no current suspicion that you have liver cancer (HCC)

Who may not be able to join:

No specific exclusion criteria have been listed for this trial (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 20 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of Aarhus

Registry

ClinicalTrials.gov

Start date

1 January 2026

Est. completion

30 June 2028

Where this trial is recruiting

🇩🇰 Denmark

Primary endpoints

HCC-related mortality

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov